SHANNON WEAVER: Open Payments
NPI 1457903791 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 49 payments from 17 companies in 2025. Trend: 2023 $1,331 · 2024 $1,974 · 2025 $1,066
Food & beverage: $1,011Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $206 |
| ABBVIE INC. | 10 | $181 |
| Amgen Inc. | 4 | $105 |
| GlaxoSmithKline, LLC. | 4 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| PFIZER INC. | 2 | $48 |
| Novo Nordisk Inc | 2 | $37 |
| Radius Health, Inc. | 1 | $31 |
Products named: TREMFYA, RINVOQ, OTEZLA, BENLYSTA, ORENCIA, COSENTYX, FARXIGA, SKYRIZI.
Industry payments across NV — which companies pay providers there.
